Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal
Canadian Journal of Physiology and Pharmacology · 2024
DOI: 10.1139/cjpp-2023-0314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Raquel R Soares-Santos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Tramadol, Cannabinoids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: FAPEMIG, National Council for Scientific and Technological Development, T.R.L.R.
Abstract (Originalsprache)
Tramadol, an analgesic classified as an “atypical opioid”, exhibits both opioid and non-opioid mechanisms of action. This study aimed to explore these mechanisms, specifically the opioid-, cannabinoid-, nitric oxide-, and potassium channel-based mechanisms, which contribute to the peripheral antinociception effect of tramadol, in an experimental rat model. The nociceptive threshold was determined using paw pressure withdrawal. To examine the mechanisms of action, several substances were administered intraplantarly: naloxone, a non-selective opioid antagonist (50 µg/paw); AM251 (80 µg/paw) and AM630 (100 µg/paw) as the selective antagonists for types 1 and 2 cannabinoid receptors, respectively; nitric oxide synthase inhibitors L-NOArg, L-NIO, L-NPA, and L-NIL (24 µg/paw); and the enzyme inhibitors of guanylatocyclase and phosphodiesterase of cGMP, ODQ, and zaprinast. Additionally, potassium channel blockers glibenclamide, tetraethylammonium, dequalinium, and paxillin were used. The results showed that opioid and cannabinoid receptor antagonists did not reverse tramadol's effects. L-NOarg, L-NIO, and L-NPA partially reversed antinociception, while ODQ completely reversed, and zaprinast enhanced tramadol's antinociception effect. Notably, glibenclamide blocked tramadol's antinociception in a dose-dependent manner. These findings suggest that tramadol's peripheral antinociception effect is likely mediated by the nitrergic pathway and sensitive ATP potassium channels, rather than the opioid and cannabinoid pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
ORCID-Profile: Thiago L Romero, Igor D G Duarte
Förderung
- FAPEMIG
- National Council for Scientific and Technological Development
- T.R.L.R
Zitieren
APA
Soares-Santos, R. R., Machado, D. P., Romero, T. L., & Duarte, I. D. G. (2024). Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0314
Vancouver
Soares-Santos RR, Machado DP, Romero TL, Duarte IDG. Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0314
BibTeX
@article{SoaresSantos2024,
author = {Soares-Santos, Raquel R and Machado, Daniel P and Romero, Thiago L and Duarte, Igor D G},
title = {Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
doi = {10.1139/cjpp-2023-0314}
}
EUVIMED